FindTrial
Sign In

To compare the effect of IV Lignocaine 60mg versus 30mg pretreatment for preventing the pain of Propofol injection.

Comparitive study between effect of IV Lignocaine 60mg versus 30mg as pretreatment for prevention of pain during Propofol induction - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/08/093677
Enrollment
50
Registered
2025-08-26
Start date
Unknown
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: 3- Administration

Interventions

Intervention1: Intravenous lignocaine 30mg: IV lignocaine either 30mg is given before Injecting IV Propofol Control Intervention1: Intravenous lignocaine 60mg: IV lignocaine 60mg is given before injec

Sponsors

Sapthagiri Institute of Medical Sciences and Research Centre
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1]Patients willing for the study- informed consent 2]ASA 1 and 2

Exclusion criteria

Exclusion criteria: 1]ASA 3 and 4 patients 2]Patients with hypersensitivity or allergies to study drug. 3]Uncontrolled Diabetes and Hypertension, Cardiovascular diseases,liver and kidney disorders, psychiatric disorders

Design outcomes

Primary

MeasureTime frame
IV Lignocaine 60mg will be better than IV Lignocaine 30mg as pretreatment in preventing Propofol injection pain.Timepoint: Haemodynamic parameters will be recorded at 15seconds and 1min after Propofol injection, Pain assessment will be done 5,10 and 15 seconds after Propofol injection—

Secondary

MeasureTime frame
NILTimepoint: NIL—

Countries

India

Contacts

Public ContactDr Prashanth Prabhu J

Sapthagiri Institute of Medical Sciences and Research Centre

prashanthjnpl@gmail.com9035067161

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026